Skip to main content
. 2017 Aug 31;10:4305–4313. doi: 10.2147/OTT.S144014

Figure 4.

Figure 4

Analysis of NF-κB1 and Bcl-2 protein expressions in glioma cells by Western blotting.

Notes: Numbers 1–3 are blank group, no-load plasmid group, and NF-κB1 shRNA plasmid group; 4–6 are blank group, no-load plasmid group, and NF-κB1 overexpression + Bcl-2 shRNA plasmid group; 7–9 are no-load plasmid group, NF-κB1 overexpression plasmid group, and Bcl-2 shRNA plasmid group; (A, C, and E) U87 cells and (B, D, and F) SHG44 cells; relative molecular weight: NF-κB1: 50,000, Bcl-2: 26,000, and GAPDH: 36,000. NF-κB1 shRNA, NF-κB1 silencing; Bcl-2 shRNA, Bcl-2 silencing.

Abbreviation: NF-κB1, nuclear factor-kappa B1.